GLTO Stock Analysis: Buy, Sell, or Hold?
GLTO - Galecto, Inc. Common Stock
$25.12
-1.12 (-4.27%)
▼
5d:
+0.62%
30d:
+9.15%
90d:
+241.7%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Get Alerted When GLTO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GLTO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GLTO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GLTO is currently trading at $25.11, which is considered fair relative to its 30-day fair value range of $21.47 to $27.95.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $22.18, while resistance sits at $32.00. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+22.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $22.18, while resistance sits at $32.00. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+22.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$21.47 -
$27.95
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 22.0% below Wall St target ($32.00)
Fair Price Analysis
30-Day Fair Range
$21.47 -
$27.95
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$22.18
Resistance Level
$32.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-16.82
Wall Street Target
$32.00
(+22.0%)
Last updated: February 02, 2026 11:17 AM ET
Data refreshes hourly during market hours. Next update: 12:17 PM
Data refreshes hourly during market hours. Next update: 12:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLTO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
